Fremont, California
United States
32
2007-10-04
19
2009-02-10
These are the the leading inventors for applications assigned to Scios, Inc.:
Scios, Inc. based in Fremont, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Indole-type derivatives as inhibitors of p38 kinase
#2 | 2007-09-11 β Patent 7,268,139 granted on 2007-09-11Methods of promoting osteogenesis
#3 | 2007-03-22Methods to synthesize indoles as precursors for pharmaceuticals
#4 | 2007-03-22Fused bicyclic inhibitors of TGFbeta
#5 | 2007-03-13 β Patent 7,189,726 granted on 2007-03-13Benzofuran derivatives as inhibitors of p38-Ξ± kinase
#6 | 2007-03-13 β Patent 7,189,739 granted on 2007-03-13Compounds and methods to treat cardiac failure and other disorders
#7 | 2007-02-27 β Patent 7,183,070 granted on 2007-02-27Inhibition of AΞ² production by Ξ²-secretase BACE2
#8 | 2006-11-16Method of treating myelodysplastic syndromes
#9 | 2006-09-07Heterocyclic amides and sulfonamides
#10 | 2006-08-17Novel beta-secretase and modulation of beta-secretase activity
#11 | 2006-07-20Immunoassays for brain natriuretic propeptide
#12 | 2006-04-25 β Patent 7,033,812 granted on 2006-04-25Ξ²-secretase and modulation of Ξ²-secretase activity
#13 | 2006-04-18 β Patent 7,030,083 granted on 2006-04-18Treatment of eclampsia and preeclampsia
#14 | 2006-04-13Treatment of multiple myeloma by inhibition of p38 MAP kinase
#15 | 2006-03-28 β Patent 7,018,799 granted on 2006-03-28Methods for identifying inhibitors of neuronal degeneration
#16 | 2006-03-16Treatment of osteolytic lesions associated with multiple myeloma by inhibition of p38 map kinase
#17 | 2006-03-09Treatment of multiple myeloma by p38 MAP kinase and proteasome inhibition
#18 | 2006-02-09 β Patent 7,179,790 granted on 2007-02-20Brain natriuretic peptide
#19 | 2005-11-03Treatment of malignant gliomas with TGF-beta inhibitors
#20 | 2005-10-13 β Patent 7,186,526 granted on 2007-03-06Recombinant fibroblast growth factor analogs
#21 | 2005-10-06Quinazoline derivatives as medicaments
#22 | 2005-09-22 β Patent 7,202,344 granted on 2007-04-10Secreted factors
#23 | 2005-08-11 β Patent 7,119,199 granted on 2006-10-10Process for the preparation of pyridopyrimidones
#24 | 2005-08-04Indole-type inhibitors of p38 kinase
#25 | 2005-06-16 β Patent 7,244,441 granted on 2007-07-17Stents and intra-luminal prostheses containing map kinase inhibitors
#26 | 2005-06-07 β Patent 6,903,096 granted on 2005-06-07Quinazoline derivatives as medicaments
#27 | 2005-06-02Vascular endothelial growth factor dimers
#28 | 2005-05-24 β Patent 6,897,030 granted on 2005-05-24Immunoassays for human brain natriuretic peptide
#29 | 2005-05-10 β Patent 6,890,938 granted on 2005-05-10Indole-type inhibitors of p38 kinase
#30 | 2005-05-03 β Patent 6,887,848 granted on 2005-05-03Vascular endothelial growth factor variants
#31 | 2005-03-08 β Patent 6,864,260 granted on 2005-03-08Indole-type derivatives as inhibitors of p38 kinase
#32 | 2005-01-06 β Patent 7,223,766 granted on 2007-05-29Bi-cyclic pyrimidine inhibitors of TGFΞ²
278326 β